HC2	COBAS	positive for round 1 CIN2	972	1053	HC2 and COBAS were concordant positive for 91 % of round 1 CIN2 and 98 % of CIN3+
HPV 16	non-HPV 16/18	CIN3+ association	1055	1248	CIN3+ was significantly associated with HPV 16 (Odds Ratio [OR] 5.11; 95 % confidence interval [CI] 2.30, 11.37), but not HPV 18 (OR 2.62; 95 % CI 0.73, 9.49), vs. non-HPV 16/18 HPV at baseline
HPV 16	non-HPV 16/18	CIN3+ association	1055	1249	CIN3+ was significantly associated with HPV 16 (Odds Ratio [OR] 5.11; 95 % confidence interval [CI] 2.30, 11.37), but not HPV 18 (OR 2.62; 95 % CI 0.73, 9.49), vs. non-HPV 16/18 HPV at baseline.
HC2	COBAS	positive for round 1 CIN3+	972	1053	HC2 and COBAS were concordant positive for 91 % of round 1 CIN2 and 98 % of CIN3+
HPV 16	HPV 18	CIN3+ association	1055	1248	CIN3+ was significantly associated with HPV 16 (Odds Ratio [OR] 5.11; 95 % confidence interval [CI] 2.30, 11.37), but not HPV 18 (OR 2.62; 95 % CI 0.73, 9.49), vs. non-HPV 16/18 HPV at baseline
HPV 16	HPV 18	CIN3+ association	1055	1214	CIN3+ was significantly associated with HPV 16 (Odds Ratio [OR] 5.11; 95 % confidence interval [CI] 2.30, 11.37), but not HPV 18 (OR 2.62; 95 % CI 0.73, 9.49),
